Okay but the product is not failing, so why is this relevant? Can you not just be happy that something is going in the right direction instead of putting a negative spin on every positive development?
This isn't a new pathway, it's a topical anti androgen. It's not going to fail at this point unless the results don't impress past the 6 month point, which is unlikely given it's relative strength to what we already know works but isn't approved for Androgenetic Alopecia. The degrader could fail, but that's a different conversation.